Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q0EF
|
|||
| Former ID |
DNCL003122
|
|||
| Drug Name |
ITI-007
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Depression [ICD-11: 6A70-6A7Z] | Phase 3 | [1] | |
| Insomnia [ICD-11: 7A00-7A0Z] | Phase 3 | [2], [3] | ||
| Schizophrenia [ICD-11: 6A20] | Phase 3 | [2], [3] | ||
| Major depressive disorder [ICD-11: 6A70.3; ICD-10: F32.2] | Phase 2 | [1] | ||
| Company |
Intra-Cellular Therapies
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H28FN3O
|
|||
| Canonical SMILES |
CN1CCN2C3CCN(CC3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F
|
|||
| InChI |
1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1
|
|||
| InChIKey |
HOIIHACBCFLJET-SFTDATJTSA-N
|
|||
| CAS Number |
CAS 313369-37-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02469155) A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment. | |||
| REF 3 | Clinical pipeline report, company report or official report of Intra-Cellular Therapies. | |||
| REF 4 | Clinical pipeline report, company report or official report of Intra-Cellular Therapies, Inc. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.